Drug-Induced Liver Injury Due to Doxycycline: A Case Report and Review of Literature

Nikola Nikolajevic1, Milan Nikolajevic1, Ivana Pantic2

  • 1Internal Medicine, University of Belgrade, Faculty of Medicine, Belgrade, SRB.

Cureus
|June 5, 2024
PubMed

Insights

Doxycycline, an antibiotic, can rarely cause drug-induced liver injury (DILI) presenting as hepatocellular damage. Early recognition and discontinuation of doxycycline led to complete recovery in a patient with Lyme disease.

Area of Science:

  • Hepatology
  • Pharmacology
  • Infectious Diseases

Background:

  • Antibiotics are a leading cause of drug-induced liver injury (DILI) globally.
  • While amoxicillin/clavulanic acid and nitrofurantoin are common causes, tetracyclines are rare offenders.
  • Minocycline is more frequently implicated in DILI than doxycycline among tetracyclines.

Observation:

  • A healthy 28-year-old male developed acute liver injury with a hepatocellular pattern five days after starting doxycycline for Lyme disease.
  • Symptoms included nausea, vomiting, fatigue, and elevated transaminases.
  • Exclusion of other potential causes like infections, autoimmune disorders, and malignancies was performed.

Findings:

  • Doxycycline was identified as the causative agent for the patient's liver injury.
  • Diagnosis was supported by the temporal relationship between doxycycline intake and symptom onset.
  • Complete resolution of liver injury occurred upon cessation of doxycycline.

Implications:

  • Doxycycline should be recognized as a potential cause of drug-induced liver injury.
  • Unlike minocycline, doxycycline exhibits a shorter latency period for DILI.
  • Prompt diagnosis and withdrawal of doxycycline can prevent severe liver damage and ensure patient recovery.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
825
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
2.6K
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
495
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
647
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
117